XML 46 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value - Additional Information (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 31, 2023
USD ($)
Installment
Apr. 07, 2022
Oct. 31, 2024
USD ($)
Jul. 31, 2024
USD ($)
Apr. 30, 2024
USD ($)
Installment
Apr. 30, 2022
USD ($)
Installment
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
Jun. 30, 2023
USD ($)
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2018
USD ($)
Installment
shares
Nov. 21, 2022
shares
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Change in fair value of warrant liability                 $ (61)      
Loss on debt extinguishment               $ (2,952)   $ (2,952)    
2018 Notes | Series G Preferred Stock                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Warrant issued to purchase shares | shares             613,333   613,333      
Contingent Consideration                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Interest expense due to passage of time and fixed payment schedule             $ 1,000 $ 100 $ 2,100 $ 1,000    
Warrant Liabilities                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Warrant issued to purchase shares | shares                       5,000,000
Change in fair value of warrant liability                 $ 100      
Integrated Diagnostics, Inc | Contingent Consideration                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Business acquisition description                 requires additional consideration to be paid by the Company to such shareholders upon attainment of a three-consecutive month      
Business acquisition contingent consideration gross margin target                     $ 2,000  
Business acquisition contingent consideration gross margin target period                     7 years  
Integrated Diagnostics, Inc | Contingent Consideration | Third Amendment to APA Agreement                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Contingent consideration number of installments | Installment           5            
Milestone payment           $ 2,000            
Percentage of interest on installment payments   10.00%                    
Integrated Diagnostics, Inc | Contingent Consideration | Scenario Forecast | Third Amendment to APA Agreement                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Contingent consideration number of installments | Installment 3       1              
Milestone payment $ 3,000     $ 8,400 $ 5,000              
Exit fee payment     $ 6,100                  
Integrated Diagnostics, Inc | Common Stock | Contingent Consideration                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Business acquisition description                 If Indi elected to not exercise its option, the Company had 12 months to repurchase the common stock in two equal and consecutive quarterly cash installments totaling $37.0 million.      
Contingent consideration shares | shares                     2,520,108  
Contingent consideration number of installments | Installment                     8  
Contingent consideration arrangements, common shares, redemption amount                 $ 4,600   $ 37,000  
Repayments of debt                 9,300      
Business combination contingent consideration final payment                 $ 37,000      
Integrated Diagnostics, Inc | Common Stock | Contingent Consideration | Repurchase                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Contingent consideration cash payment                     $ 37,000  
Minimum | Contingent Consideration                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range                 11.00%      
Maximum | Contingent Consideration                        
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                        
Percentage of probabilities of contingent consideration successful achievement of specified product gross margin targets discount rates range                 16.00%